Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma

MLA

Yuekun Wang, et al. “Progress in Phase III Clinical Trials of Molecular Targeted Therapy and Immunotherapy for Glioblastoma.” Cancer Innovation, vol. 2, Mar. 2023, pp. 114–30. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a9be66b58bb4c5e4bec97b5e81eb71d8&authtype=sso&custid=ns315887.

APA

Yuekun Wang, Shenglan Li, Yichen Peng, Wenbin Ma, Yu Wang, & Wenbin Li. (2023). Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma. Cancer Innovation, 2, 114–130.

Chicago

Yuekun Wang, Shenglan Li, Yichen Peng, Wenbin Ma, Yu Wang, and Wenbin Li. 2023. “Progress in Phase III Clinical Trials of Molecular Targeted Therapy and Immunotherapy for Glioblastoma.” Cancer Innovation 2 (March): 114–30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a9be66b58bb4c5e4bec97b5e81eb71d8&authtype=sso&custid=ns315887.